Diabetes and cardiovascular disease: time for a multifactorial approach.
Congress Presentation
About the speaker
Professor John Eric Deanfield
4 more presentations in this session
Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?
Speaker: Professor T. Luscher (London, GB)
GLP-1 receptor agonists: the cardiovascular benefits beyond glucose control.
Speaker: Professor F. Krag Knop (Copenhagen, DK)
Translating GLP-1 trial outcomes to cardiology practice: which patients will benefit? .
Speaker: Professor L. Ryden (Stockholm, SE)
Discussion and summary - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?
Speaker: Professor T. Luscher (London, GB) Professor J. Deanfield (London, GB)
Access the full session
Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)
About the event
